Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study

Carregando...
Imagem de Miniatura
Citações na Scopus
24
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Citação
BMC OPHTHALMOLOGY, v.12, article ID 40, 6p, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: To investigate indocyanine green angiography (ICGA) findings in patients with long-standing Vogt-Koyanagi-Harada (VKH) disease and their correlation with disease activity on clinical examination as well as with systemic corticosteroid therapy. Methods: Twenty-eight patients (51 eyes) with long-standing (>= 6 months from disease onset) VKH disease whose treatment was tapered based only in clinical features were prospectively included at a single center in Brazil. All patients underwent standardized clinical evaluation, which included fundus photography, fluorescein angiography and ICGA. Clinical disease activity was determined based in the Standardization in Uveitis Nomenclature Working Group. Fisher exact test and logistic regression models were used for statistical analysis. Results: Disease-related choroidal inflammation on ICGA was observed in 72.5% (31 of 51 eyes). Angiographic findings suggestive of (choroidal and/or retinal) disease activity were not observed on FA. Clinically active disease based on clinical evaluation was observed in 41.2% (21 of 51 eyes). In these 21 eyes, disease-related choroidal inflammation on ICGA was observed in 76.2% (16 of 21 eyes); in the remaining eyes (without clinical active disease) disease-related choroidal inflammation on ICGA was observed in 70.0% (21 of 30 eyes). In respect to systemic corticosteroid therapy, 10 patients (18 of 51 eyes) were under treatment with prednisone. In these 10 (18 of 51 eyes) patients, disease-related choroidal inflammation on ICGA was observed in 83.3% (15 of 18 eyes); in the remaining patients (33 of 51 eyes) disease-related choroidal inflammation on ICGA was observed in 66.7% (22 of 33 eyes). Conclusion: ICGA findings suggestive of disease-related choroidal inflammation were observed in a considerable proportion of patients with long-standing VKH disease, independent of the inflammatory status of the disease on clinical examination or current use of systemic corticosteroid. Therefore, the current study reinforces the crucial role of ICGA to assist the management and treatment of patients with long-standing VKH disease.
Palavras-chave
Angiography, Indocyanine green, Choroid, Diagnosis, Inflammation, Vogt-Koyanagi-Harada
Referências
  1. Bacsal K, 2008, AM J OPHTHALMOL, V145, P480, DOI 10.1016/j.ajo.2007.10.012
  2. Bouchenaki Nadia, 2011, J Ophthalmic Vis Res, V6, P241
  3. Bouchenaki N, 2001, OPHTHALMOLOGY, V108, P54, DOI 10.1016/S0161-6420(00)00428-0
  4. da Silva FT, 2009, AM J OPHTHALMOL, V148, P939, DOI 10.1016/j.ajo.2009.06.029
  5. Da Silva FTBCG, 2009, AM J OPHTHALMOL, V147, P339, DOI 10.1016/j.ajo.2008.08.034
  6. Fardeau Christine, 2007, International Ophthalmology, V27, P163, DOI 10.1007/s10792-006-9024-7
  7. GUYER DR, 1994, ARCH OPHTHALMOL-CHIC, V112, P1057
  8. Herbort Carl P., 2007, International Ophthalmology, V27, P173, DOI 10.1007/s10792-007-9060-y
  9. Herbort CP, 1998, OPHTHALMOLOGY, V105, P432, DOI 10.1016/S0161-6420(98)93024-X
  10. Heussen FM, 2011, OPHTHAL SURG LAS IM, V42, P272, DOI 10.3928/15428877-20110505-01
  11. Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057
  12. Kawaguchi Tatsushi, 2010, International Ophthalmology, V30, P41, DOI 10.1007/s10792-008-9288-1
  13. Kishi S, 2001, JPN J OPHTHALMOL, V45, P640, DOI 10.1016/S0021-5155(01)00428-2
  14. Lafaut BA, 1998, GRAEF ARCH CLIN EXP, V236, P513, DOI 10.1007/s004170050114
  15. Prunte C, 1996, AM J OPHTHALMOL, V121, P26
  16. Rao Narsing A., 2007, International Ophthalmology, V27, P81, DOI 10.1007/s10792-006-9029-2
  17. Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4
  18. Read RW, 2006, AM J OPHTHALMOL, V142, P119, DOI 10.1016/j.ajo.2006.02.049
  19. Stanga PE, 2003, OPHTHALMOLOGY, V110, P15, DOI 10.1016/S0161-6420(02)01563-4
  20. Suzuki S, 1999, JPN J OPHTHALMOL, V43, P327, DOI 10.1016/S0021-5155(99)00016-7
  21. Tanigawa Minoru, 2012, Case Rep Ophthalmol, V3, P38, DOI 10.1159/000336451
  22. Vasconcelos-Santos DV, 2010, RETINA-J RET VIT DIS, V30, P33, DOI 10.1097/IAE.0b013e3181c5970d
  23. Wu WJ, 2007, AM J OPHTHALMOL, V143, P900, DOI 10.1016/j.ajo.2006.11.050
  24. Yannuzzi LA, 2011, AM J OPHTHALMOL, V151, P745, DOI 10.1016/j.ajo.2011.01.043
  25. Zhao C, 2009, OCUL IMMUNOL INFLAMM, V17, P282, DOI 10.1080/09273940902807930